These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 5812649)

  • 1. [Antifungal drugs].
    Fukushima K
    Jibiinkoka; 1969 Oct; 40(10):751-6. PubMed ID: 5812649
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antifungal agents. I].
    Fossati C
    Clin Ter; 1976 Jun; 77(5):473-93. PubMed ID: 795591
    [No Abstract]   [Full Text] [Related]  

  • 3. Introduction to antifungal drugs.
    Dismukes WE
    Clin Infect Dis; 2000 Apr; 30(4):653-7. PubMed ID: 10770726
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacokinetics of imidazole-antimycotics (author's transl)].
    Plempel M
    Mykosen; 1980 Jan; 23(1):16-27. PubMed ID: 7383054
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fungal infections: involved species and minimal inhibitory concentrations of common antifungal agents].
    Dei-Cas E; Fruit J; Poulain D; Dutoit E; Chendid H; Vernes A
    Ann Biol Clin (Paris); 1984; 42(6):415-8. PubMed ID: 6543419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hamycin in experimental keratomycosis.
    Ahuja OP; Bal A; Nath K; Nema HV
    J All India Ophthalmol Soc; 1967 Feb; 15(1):19-22. PubMed ID: 5618261
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical examination of volon-A tincture in the therapy of mycoses of the feet (Tinea pedum)].
    Grimmer H
    Z Haut Geschlechtskr; 1970 Sep; 45(17):597-600. PubMed ID: 5455933
    [No Abstract]   [Full Text] [Related]  

  • 8. N, N, N-trimethylamphotericin B methyl ester chloride (DMS-AME): in vitro and in vivo antifungal activity studies in comparison with fungizone.
    Zaremba M; Borowski J; Feliński J; Rozkiewicz D; Rozkiewicz M; Zaremba K; Czerwiński A; Borowski E
    J Chemother; 1989 Jul; 1(4 Suppl):243-5. PubMed ID: 16312386
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of the results of laboratory-controlled treatment of vaginal mycoses].
    Prosiecki R; Bogaczewicz A; Pawlik B
    Pol Tyg Lek; 1984 Mar; 39(13):433-6. PubMed ID: 6540874
    [No Abstract]   [Full Text] [Related]  

  • 10. Fungal resistance in Cambodian children with acquired immunodeficiency syndrome.
    Krcmery V; Augustinova A; Babelova O; Doczeova A; Liskova A
    Pediatr Infect Dis J; 2006 May; 25(5):470. PubMed ID: 16645523
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeting Candida spp. to develop antifungal agents.
    Salci TP; Negri M; Abadio AKR; Svidzinski TIE; Kioshima ÉS
    Drug Discov Today; 2018 Apr; 23(4):802-814. PubMed ID: 29353694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical use of Pimaricin vaginal suppository and ointment for mycosis of the vagina and external genitalia].
    Mitani Y; Kubota K; Matsui T; Shimomura M
    Sanfujinka No Jissai; 1970 Apr; 19(4):429-31. PubMed ID: 5468617
    [No Abstract]   [Full Text] [Related]  

  • 13. Candida krusei arthritis in a patient with hematologic malignancy: successful treatment with voriconazole.
    Sili U; Yilmaz M; Ferhanoglu B; Mert A
    Clin Infect Dis; 2007 Oct; 45(7):897-8. PubMed ID: 17806057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Yeast infections: causative agents and their antifungal resistance in hospitalized pediatric patients and HIV-positive adults].
    Rodero L; Boutureira M; Demkura H; Burkett A; Fernández C; Losso M; Jáuregui Rueda H; Monticelli A; Vitale R; Canteros C; Hochenfellner F; Vivot W; Davel G
    Rev Argent Microbiol; 1997; 29(1):7-15. PubMed ID: 9229726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis.
    Pinto PM; Weikert-Oliveira Rde C; Lyon JP; Cury VF; Arantes RR; Koga-Ito CY; Resende MA
    Microbiol Res; 2008; 163(5):579-85. PubMed ID: 16962755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal drugs.
    Treat Guidel Med Lett; 2008 Jan; 6(65):1-8. PubMed ID: 18157085
    [No Abstract]   [Full Text] [Related]  

  • 17. Antifungal pharmacokinetics and pharmacodynamics: bridging from the bench to bedside.
    Hope WW; Drusano GL
    Clin Microbiol Infect; 2009 Jul; 15(7):602-12. PubMed ID: 19673971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of in vitro antifungal susceptibility testing.
    Espinel-Ingroff A
    Rev Esp Quimioter; 2000 Jun; 13(2):161-6. PubMed ID: 10918088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antifungal activity of 2-(2'-hydroxy-5'-aminophenyl)benzoxazole in Candida spp. strains.
    Daboit TC; Stopiglia CD; Carissimi M; Corbellini VA; Stefani V; Scroferneker ML
    Mycoses; 2009 Nov; 52(6):507-10. PubMed ID: 19302462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micafungin: a sulfated echinocandin.
    Hashimoto S
    J Antibiot (Tokyo); 2009 Jan; 62(1):27-35. PubMed ID: 19132058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.